Product Name: Capecitabine CAS NO: 154361-50-9
Chemical & Physical Properties:
Appearance :white powder
Boiling Point:437.87℃ at 760 mmHg
Capecitabine is an anti-metabolic fluoropyrimidine deoxynucleoside carbamate drug that can be converted into 5-FU in the body. It is developed by Roche, and its trade name is Xeloda, which can inhibit cell division and interference. RNA and protein synthesis. It is suitable for the further treatment of paclitaxel and advanced primary or metastatic breast cancer that is ineffective in chemotherapy including anthracycline antibiotics. Mainly used for the treatment of advanced primary or metastatic breast cancer, rectal cancer, colon cancer and gastric cancer.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.